To evaluate any serious harmful potentials of a drug, toxicology assays are conducted, while DMPK assays are carried out to support ADME properties assessment. These studies are performed by our experts in bioanalysis, who check accurate dosage levels and measure drug and metabolite concentration levels in biological matrices.
In parallel, the chemical properties of the drug candidate, such as solubility or stability, also influence its performance. An efficient chemical development route design and formulation development are also key to ensuring the efficacy of a drug candidate.
To maintain the quality of your drug from lab to shelf, our analytical development and QC team has extensive experience in designing reliable and robust analytical test methods. While moving from bench to bedside, our clinical trial supply experts can support the manufacturing of your medicinal products for use in Phases I–IV clinical studies, as well as compassionate use/expanded access programs.
Our preclinical solutions cover:
